Grilo, A. M., Klaus, C., McDonald, A., Gollob, J., Weiss, M., O'Connor, O. A., . . . Lue, J. K. (2022). Precision Targeting of MYD88 Mutant DLBCL Using the Novel Combination of Irakimids and BCL2 Inhibition. Blood, 140(Supplement 1), 8862-8864. https://doi.org/10.1182/blood-2022-159567

Grilo, Andre M., Christine Klaus, Alice McDonald, Jared Gollob, Matt Weiss, Owen A. O'Connor, Gilles Salles, Jayanta Chaudhuri, and Jennifer Kimberly Lue. "Precision Targeting of MYD88 Mutant DLBCL Using the Novel Combination of Irakimids and BCL2 Inhibition." Blood 140, no. Supplement 1 (2022): 8862-8864. https://doi.org/10.1182/blood-2022-159567.

Grilo, Andre M., et al. "Precision Targeting of MYD88 Mutant DLBCL Using the Novel Combination of Irakimids and BCL2 Inhibition." Blood, vol. 140, no. Supplement 1, 2022, pp. 8862-8864, https://doi.org/10.1182/blood-2022-159567.